[Clinical evaluation of amitryptyline hydrochloride in the treatment of depression].
Thirty subjects between 18 and 66 years of age with overt symptoms of depression were followed during treatment with amytryptiline. Daily dose was 75 mg in three parts for a period of three months. Thirteen subjects showed total remission from the tenth week; 15 showed significant improvement from the third week; 2 showed no change. Side effects were mild and required no medical intervention.
D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D000639:Amitriptyline
Valoracion clinica del clorhidrato de amitriptilina en el tratamiento de la depresion